Thyroid cancer is the most common endocrine malignancy, affecting nearly 600,000 new
patients worldwide. Treatment with the BRAF inhibitor sorafenib partially prolongs …

Aim The aim of this study was to assess the feasibility of targeted therapy of thyroid
carcinoma, first exploring potential targets BRAF, EGFR and CD44v6 in patient material …

Objective Reminiscence therapy (RT) ameliorates psychological problems and quality of life
in cancer patients. However, no study reports its effect on older papillary thyroid carcinoma …

Objective To explore the diagnostic value of contrast-enhanced ultrasound (CEUS) of
qualitative and quantitative parameters for differentiating differentiated thyroid cancers from …

Purpose The incidence of thyroid cancer is growing fast and surgery is the most significant
treatment of it. For patients with unilateral cN0 papillary thyroid cancer whether to dissect …

Objective: To determine the sensitivity of ACR-TIRADS scoring by comparing its results with
those obtained on biopsy of respective specimens. Method: This prospective study including …

Objective This study aimed to establish and validate the nomograms for predicting overall
survival (OS) probabilities in differentiated thyroid cancer (DTC) patients who received and …

Objective To explore the feasibility of the postoperative diagnostic 131I whole-body planar
scans (Dx-WBS) in papillary thyroid cancer (PTC) patients, and to clarify its value for …

Background It remains unclear whether the time interval between total thyroidectomy and
radioactive iodine (RAI) therapy influences clinical outcomes in papillary thyroid carcinoma …

Background The prognosis with current management approach of anaplastic thyroid
carcinoma (ATC) remains poor, and new effective treatments are greatly needed …